Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00073411
Status:
COMPLETED
Last Update Posted:
2007-07-31
First Post:
2003-11-20
Brief Title:
Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Study Overview
Official Title:
Duloxetine Versus Escitalopram and Placebo in the Treatment of Patients With Major Depression
Status:
COMPLETED
Status Verified Date:
2007-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purposes of this study are to determine
The safety of duloxetine and any side effects that might be associated with it
How duloxetine compares to escitalopram and placebo an inactive ingredient
The safety of duloxetine and any side effects that might be associated with it
How duloxetine compares to escitalopram and placebo an inactive ingredient
Detailed Description:
duloxetine 60mg - 120mg escitalopram 10mg - 20mg and placebo 8-month
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| F1J-US-HMCR | None | None | None |